Patents Assigned to Glenmark Pharamceuticals S.A.
  • Chromane derivatives as TRPV3 modulators
    Patent number: 8492568
    Abstract: The present invention provides chromane derivatives as transient receptor potential vanilloid (TRPV) modulators. In particular, the compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: July 23, 2013
    Assignee: Glenmark Pharamceuticals S.A.
    Inventors: V. S. Prasada Rao Lingam, Abraham Thomas, Javed Yusuf Khatik, Neelima Khairatkar-Joshi, Vidya Ganapati Kattige